Some
biomaterial scaffolds can positively interfere with tissue regeneration and are being developed to successfully repair the tissue function. The possibility of using epithelial cells combined with
biomaterials appears to be a new option as therapeutic application. This combination emerges as a possibility for patients with
Mayer-Rokitansky-Kuster-Hauser syndrome which requires vaginal repair and can be performed with tissue-engineered
solution containing cells and
biomaterials. It is expected that tissue-engineered
solution containing cells and
biomaterials would promote tissue repair in a more efficient, modern, and safe way. This study tested the efficiency of tissue-engineered
solution containing human
malignant melanoma cell line (HMV-II) and different
biomaterials, including Cellprene®, Membracel®, and
poly lactic-co-glycolic acid/epoxidized polyisoprene. The cells adhered better on
poly lactic-co-glycolic acid/epoxidized polyisoprene, and it was found that tissue-engineered
solution may also contain mesenchymal stem cells cultivated on
poly lactic-co-glycolic acid/epoxidized polyisoprene. Histological, immunofluorescence, and scanning electron microscopy analyses were performed. These initial in vitro results suggest that tissue-engineered
solution containing cells and
poly lactic-co-glycolic acid/epoxidized polyisoprene is a potential for tissue reconstruction.